For What Reason, PDS Biotechnology Corporation (PDSB) Stock Climbed 8.04% In Pre-market Trading.
PDS Biotechnology Corporation (PDSB), a clinical-stage biotechnological company specializing to develop unique cancer therapies centered on the PDSB proprietary Versamune T-cell activating technology, announced the publication of abstract #2501 by the American Society of Clinical Oncology (ASCO). PDSB stock price surged adjacent to the news. Get the hottest stocks to trade every day before the […]
